Atlas Venture Opportunity Fund Ii, L.p. - Net Worth and Insider Trading

Over the past 18 months, Atlas Venture Opportunity Fund Ii, L.p. made no insider transaction in Day One Biopharmaceuticals Inc (DAWN). Other recent insider transactions involving Day One Biopharmaceuticals Inc (DAWN) include a net sale of 116,607 shares made by Samuel C. Blackman , a net sale of 150,568 shares made by Jeremy Bender , and a net sale of 106,697 shares made by York Charles N Ii .

In summary, during the past 3 months, insiders sold 225,453 shares of Day One Biopharmaceuticals Inc (DAWN) in total and bought 0 shares, with a net sale of 225,453 shares. During the past 18 months, 471,785 shares of Day One Biopharmaceuticals Inc (DAWN) were sold and 2,244,684 shares were bought by its insiders, resulting in a net purchase of 1,772,899 shares.

Day One Biopharmaceuticals Inc (DAWN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Atlas Venture Opportunity Fund Ii, L.p. made no insider transaction in Disc Medicine Inc (IRON). Other recent insider transactions involving Disc Medicine Inc (IRON) include a net sale of 1,106,612 shares made by Atlas Venture Fund X, L.p. , a net sale of 297,652 shares made by Kevin Bitterman , and a net sale of 20,634 shares made by Joanne Bryce .

In summary, during the past 3 months, insiders sold 28,918 shares of Disc Medicine Inc (IRON) in total and bought 0 shares, with a net sale of 28,918 shares. During the past 18 months, 3,899,867 shares of Disc Medicine Inc (IRON) were sold and 652,175 shares were bought by its insiders, resulting in a net sale of 3,247,692 shares.

Disc Medicine Inc (IRON)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Atlas Venture Opportunity Fund Ii, L.p. made no insider transaction in Dyne Therapeutics Inc (DYN). Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 241,325 shares made by Jonathan Mcneill , a net sale of 191,946 shares made by Richard William Scalzo , and a net sale of 1,171,794 shares made by Joshua T Brumm .

In summary, during the past 3 months, insiders sold 4,515,887 shares of Dyne Therapeutics Inc (DYN) in total and bought 0 shares, with a net sale of 4,515,887 shares. During the past 18 months, 5,472,903 shares of Dyne Therapeutics Inc (DYN) were sold and 3,583,447 shares were bought by its insiders, resulting in a net sale of 1,889,456 shares.

Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Atlas Venture Opportunity Fund Ii, L.p. made 1 insider transaction in Korro Bio Inc (KRRO) with a net purchase of 17,857. Other recent insider transactions involving Korro Bio Inc (KRRO) include a net sale of 2,124 shares made by David L. Lucchino , a net purchase of 17,857 shares made by Mohamad Makhzoumi , and a net purchase of 17,857 shares made by Edward T Mathers .

In summary, during the past 3 months, insiders sold 0 shares of Korro Bio Inc (KRRO) in total and bought 178,570 shares, with a net purchase of 178,570 shares. During the past 18 months, 2,124 shares of Korro Bio Inc (KRRO) were sold and 178,570 shares were bought by its insiders, resulting in a net purchase of 176,446 shares.

Korro Bio Inc (KRRO)'s detailed insider trading history can be found in Insider Trading Tracker table.